InvestorsHub Logo
Followers 38
Posts 1440
Boards Moderated 0
Alias Born 03/07/2004

Re: cjgaddy post# 92726

Monday, 09/17/2012 6:33:08 PM

Monday, September 17, 2012 6:33:08 PM

Post# of 345969
cj, thanks. Thorpe chairing the tumor immunology confab is evidence of how far PPHM's anti-PS platform has come under the insight and stewardship of Dr. Philip Thorpe, PPHM's lead science (UTSW Prof., Dept.Pharm). I'll keep my money on Thorpe, UTSW, and PPHM. Remember the naysayers? Years ago I said Thorpe's work was Nobel quality, and echoes of that are beginning to be audible. The value Bavi, even the spin-offs from the aniti-PS platform, grow apace with each new report and discovery. Great stuff. Thorpe chairing a the tumor immunology conference speaks volumes. Fab.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News